Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

September 16, 2020

A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals

Nature Immunology
Philippos DemetriouMichael L Dustin
September 16, 2020
Review

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy

British Journal of Cancer
Hans RaskovIsmail Gögenur
September 15, 2020
Open Access

Genomic and immunologic correlates of LAG-3 expression in cancer

Oncoimmunology
Anshuman PandaShridar Ganesan
September 15, 2020
Review
Open Access

An update on GM-CSF and its potential role in melanoma management

Melanoma Management
Robert O Dillman
September 15, 2020
Open Access

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer

Oncoimmunology
Mathias VormehrÖzlem Türeci
September 16, 2020
Open Access

Immunomodulation in pomalidomide, dexamethasone, and daratumumab -treated relapsed/refractory multiple myeloma patients

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
William E PierceallAnjan Thakurta
September 18, 2020
Review
Open Access

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy

Journal of Clinical Medicine
Anne M MacphersonMartin K Oehler
September 16, 2020
Review

The Combined Use of SBRT and Immunotherapy-a Literature Review

Current Oncology Reports
Maryanne J Lubas, Sameera S Kumar
September 17, 2020
Review

The use of immune checkpoint inhibitors in routine oncology

Zeitschrift für Rheumatologie
Julian Schardt
September 15, 2020
Case Report
Open Access

Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer

Therapeutic Advances in Medical Oncology
Harry J HanRahul Aggarwal
September 18, 2020

Inflammatory colitis associated with Teriflunomide

Multiple Sclerosis and Related Disorders
Neda Zarghami EsfahaniAnnette Wundes
September 17, 2020
Review
Open Access

Biomarkers of immunotherapy in non-small cell lung cancer

Oncology Letters
Lingling WangXiaochen Wang

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy: Cancer & Parkinson

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in cancer and Parkinson’s.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/immuno-oncology/81da74c3-3bbb-4b32-8039-085a2366985c